Literature DB >> 25832917

Isolated nocturnal hypertension and subclinical target organ damage: a systematic review of the literature.

Anne Marie O'Flynn1, Jamie M Madden2, Audrey J Russell2, Ronan J Curtin3, Patricia M Kearney2.   

Abstract

Isolated nocturnal hypertension (INH) is associated with greater mortality and cardiovascular events. Subclinical target organ damage (TOD) is a prognostic marker for cardiovascular events. Our objective is to systematically summarize evidence on the association between INH and subclinical TOD. Observational population studies were considered. INH was defined as nighttime blood pressure (BP) ⩾120 and/or 70 mm Hg with daytime BP <135/85 mm Hg. We systematically searched Pubmed, EMBASE and the Cochrane Library. Abstracts were reviewed by two assessors. Potentially eligible articles were compared with inclusion criteria. The search yielded 954 titles, 13 abstracts were selected for review and four articles fulfilled inclusion criteria. INH was associated with higher ambulatory arterial stiffness index (0.4 unit vs. 0.35 unit, P<0.05), pulse wave velocity (16.2 m s(-1) vs. 14.7 m s(-1), P<0.05), central (140.4% vs. 134.0%, P<0.05) and peripheral (82.6% vs. 76.5%, P<0.01) augmentation index in a Chinese study. In the same population there was no association with left ventricular hypertrophy documented by electrocardiogram. INH was not associated with increased arterial stiffness or left venticular mass index in a Swedish study. An American study demonstrated higher left ventricular mass (152.46 g vs. 136.16 g, P=0.01) and greater odds of left ventricular hypertrophy (odds ratio 3.03, 95% confidence interval 1.02-9.05) in unadjusted analysis. There was no association with proteinuria. Evidence is inconclusive regarding the association between INH and subclinical TOD. Future research should focus on trying to elucidate the mechanisms that generate INH and contribute to the higher mortality associated with this BP pattern.

Entities:  

Mesh:

Year:  2015        PMID: 25832917     DOI: 10.1038/hr.2015.43

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  30 in total

1.  Improving the utility of the nocturnal hypertension definition by using absolute sleep blood pressure rather than the "dipping" proportion.

Authors:  William B White; Gina M Larocca
Journal:  Am J Cardiol       Date:  2003-12-15       Impact factor: 2.778

2.  Evaluation of the quality of prognosis studies in systematic reviews.

Authors:  Jill A Hayden; Pierre Côté; Claire Bombardier
Journal:  Ann Intern Med       Date:  2006-03-21       Impact factor: 25.391

Review 3.  Cardiovascular risk assessment beyond Systemic Coronary Risk Estimation: a role for organ damage markers.

Authors:  Massimo Volpe; Allegra Battistoni; Giuliano Tocci; Enrico Agabiti Rosei; Alberico L Catapano; Rosanna Coppo; Stefano del Prato; Sandro Gentile; Elmo Mannarino; Salvatore Novo; Domenico Prisco; Giuseppe Mancia
Journal:  J Hypertens       Date:  2012-06       Impact factor: 4.844

Review 4.  Comparative prognostic role of nighttime blood pressure and nondipping profile on renal outcomes.

Authors:  Costas Tsioufis; Ioannis Andrikou; Costas Thomopoulos; Dimitris Petras; Athanasios Manolis; Christodoulos Stefanadis
Journal:  Am J Nephrol       Date:  2011-03-04       Impact factor: 3.754

5.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

Authors:  D Levy; R J Garrison; D D Savage; W B Kannel; W P Castelli
Journal:  N Engl J Med       Date:  1990-05-31       Impact factor: 91.245

6.  Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy.

Authors:  D Levy; S B Labib; K M Anderson; J C Christiansen; W B Kannel; W P Castelli
Journal:  Circulation       Date:  1990-03       Impact factor: 29.690

7.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

8.  Masked nocturnal hypertension--a novel marker of risk in type 2 diabetes.

Authors:  M Wijkman; T Länne; J Engvall; T Lindström; C J Ostgren; F H Nystrom
Journal:  Diabetologia       Date:  2009-04-25       Impact factor: 10.122

9.  Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.

Authors:  Peter M Okin; Richard B Devereux; Sverker Jern; Sverre E Kjeldsen; Stevo Julius; Markku S Nieminen; Steven Snapinn; Katherine E Harris; Peter Aurup; Jonathan M Edelman; Hans Wedel; Lars H Lindholm; Björn Dahlöf
Journal:  JAMA       Date:  2004-11-17       Impact factor: 56.272

10.  2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood
Journal:  Eur Heart J       Date:  2013-06-14       Impact factor: 29.983

View more
  13 in total

1.  The deadly line linking sympathetic overdrive, dipping status and vascular risk: critical appraisal and therapeutic implications.

Authors:  Francesca Santilli; Paola Simeone; Damiano D'Ardes; Giovanni Davì
Journal:  Hypertens Res       Date:  2016-03-17       Impact factor: 3.872

2.  Masked Isolated Nocturnal Hypertension in Children and Young Adults.

Authors:  Hisayo Fujita; Seiji Matsuoka; Midori Awazu
Journal:  Pediatr Cardiol       Date:  2017-09-25       Impact factor: 1.655

3.  Isolated nocturnal hypertension in relation to host and environmental factors and clock genes.

Authors:  Jian-Feng Huang; Dong-Yan Zhang; Chang-Sheng Sheng; De-Wei An; Mingxuan Li; Yi-Bang Cheng; Qian-Hui Guo; Ying Wang; Ji-Guang Wang; Yan Li
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-08-09       Impact factor: 2.885

4.  Hemoglobin A1c and C-reactive protein are independently associated with blunted nocturnal blood pressure dipping in obesity-related prediabetes.

Authors:  Abbi D Lane-Cordova; Graziela Z Kalil; Christopher J Wagner; Amy L Sindler; Jess G Fiedorowicz; Tiwaloluwa Ajibewa; William G Haynes; Gary L Pierce
Journal:  Hypertens Res       Date:  2017-10-26       Impact factor: 3.872

Review 5.  Gastrorenal Axis.

Authors:  Pedro A Jose; Robin A Felder; Zhiwei Yang; Chunyu Zeng; Gilbert M Eisner
Journal:  Hypertension       Date:  2016-04-04       Impact factor: 10.190

6.  Blood pressure control and cardiovascular risk profile in hypertensive patients under specialist care in Argentina: Results from the CHARTER study.

Authors:  Marcos Marín; Jessica Barochiner; Pablo Rodríguez; Nicolás Renna; Carlos Castellaro; Walter Espeche; Alejandro De Cerchio; Mildren Del Sueldo; Sergio Vissani; Judith Zilberman
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-09-03       Impact factor: 3.738

Review 7.  Nocturnal Hypertension and Subclinical Cardiac and Carotid Damage: An Updated Review and Meta-Analysis of Echocardiographic Studies.

Authors:  Cesare Cuspidi; Carla Sala; Marijana Tadic; Elisa Gherbesi; Guido Grassi; Giuseppe Mancia
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-02-18       Impact factor: 3.738

8.  Isolated nocturnal hypertension is associated with increased left ventricular mass index in children.

Authors:  Tomáš Seeman; Ondřej Hradský; Jiří Gilík
Journal:  Pediatr Nephrol       Date:  2021-01-07       Impact factor: 3.714

9.  Circulating CTRP1 Levels Are Increased and Associated with the STOD in Essential Hypertension in Chinese Patients.

Authors:  Zhengjia Su; Shuya Tian; Wei Liang
Journal:  Cardiovasc Ther       Date:  2019-06-02       Impact factor: 3.023

10.  Assessment of nocturnal hypertension by ambulatory blood pressure monitoring at the forearm in people with morbid obesity.

Authors:  Giacomo Pucci; Marco D'Abbondanza; Matteo Camilli; Valeria Bisogni; Fabio Anastasio; Vito Gandolfo; Riccardo Alcidi; Natasa Mojovic; Stefano Ministrini; Graziana Lupattelli; Gaetano Vaudo
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-13       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.